Skip to main content
ARS Home » Research » Publications at this Location » Publication #146156
Title: TRANSGENIC PAPAYA: A CASE FOR WORLDWIDE CONTROL OF PAPAYA RINGSPOT VIRUS

Author
item Gonsalves, Dennis

Submitted to: Crop Protection Council British Proceedings
Publication Type: Proceedings
Publication Acceptance Date: 3/21/2003
Publication Date: 4/21/2003
Citation: Gonsalves, D. 2003. Transgenic papaya: A case for worldwide control of papaya ringspot virus. Crop Protection Council British Proceedings. p. 1029-1034.

Interpretive Summary: Papaya ringspot virus (PRSV) was detected in the main papaya growing region of Hawaii in 1992. By 1994 Hawaii's papaya industry was facing devastating damage from PRSV. Efforts to develop resistant transgenic papaya were started in the mid 1980s. By 1991, a resistant line was identified, field trialed, and subsequently released to growers in 1998. 'Rainbow' an F1 hybrid from a cross of the transgenic 'SunUp' and non-transgenic 'Kapoho' is now widely planted and has virtually saved the papaya industry in Hawaii. Other transgenic papayas have been produced for other countries and our data suggest that worldwide control of PRSV by transgenic papaya is possible. The technical and regulatory hurdles that had to be overcome in Hawaii will be discussed, along with our approach for worldwide control of PRSV.

Technical Abstract: Papaya ringspot virus (PRSV) was detected in the main papaya growing region of Hawaii in 1992. By 1994 Hawaii's papaya industry was facing devastating damage from PRSV. Efforts to develop resistant transgenic papaya were started in the mid 1980s. By 1991, a resistant line was identified, field trialed, and subsequently released to growers in 1998. 'Rainbow' an F1 hybrid from a cross of the transgenic 'SunUp' and non-transgenic 'Kapoho' is now widely planted and has virtually saved the papaya industry in Hawaii. Other transgenic papayas have been produced for other countries and our data suggest that worldwide control of PRSV by transgenic papaya is possible. The technical and regulatory hurdles that had to be overcome in Hawaii will be discussed, along with our approach for worldwide control of PRSV.